Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy

References

• Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653–660.
   PubMed Web of Science ®Google Scholar
• Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006;10:355–362.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353–364.
   PubMed Web of Science ®Google Scholar
• Spranger J, Pfeiffer AP. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2001;109:S438–S450.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450–1452.
   PubMed Web of Science ®Google Scholar
• Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Invest Ophthalmol Vis Sci 2007;48:858–865.
   PubMed Web of Science ®Google Scholar
• Li G, Tang J, Du Y, Lee CA, Kern TS. Beneficial effects of novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia. Mol Vis 2011;17:3156–3165.
   PubMed Web of Science ®Google Scholar
• Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 2007;10:149–166.
   PubMedGoogle Scholar
• Salam A, Mathew R, Sivaprasad S. Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmol 2011;89:405–411.
   PubMed Web of Science ®Google Scholar
• Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res 2011;71:6561–6566.
   PubMed Web of Science ®Google Scholar
• Austin KM, Covic L, Kuliopulos A. Matrix metalloproteases and PAR1 activation. Blood 2013;121:431–439.
   PubMed Web of Science ®Google Scholar
• Tsopanoglou NE, Maragoudakis ME. Thrombin’s central role in angiogenesis and pathophysiological processes. Eur Cytokine Netw 2009;20:171–179.
   PubMed Web of Science ®Google Scholar
• Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120:303–313.
   PubMed Web of Science ®Google Scholar
• Blackburn JS, Brinckerhoff CE. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol 2008;173:1736–1746.
   PubMed Web of Science ®Google Scholar
• Tsopanoglou NE, Maragoudakis ME. Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. Semin Thromb Hemost 2007;33:680–687.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Tressel SL, Kaimal R, Balla M, Lam FH, Covic L, et al. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy. Cancer Res 2010;70:5880–5890.
   PubMed Web of Science ®Google Scholar
• Yin YJ, Salah Z, Maoz M, Ram SCE, Ochayon S, Neufeld G, et al. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J 2003;17:163–174.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Covic L, Sevigny LM, Kaneider NC, Lazarides K, Azabdaftari G, et al. Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol Cancer Ther 2008;7:2746–2757.
   PubMed Web of Science ®Google Scholar
• Cho JR, Rollini F, Franchi F, Ferrante E, Angiolillo DJ. Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar. Vasc Health Risk Manage 2014;10:177–188.
   PubMedGoogle Scholar
• Sakai T, Nambu T, Katoh M, Uehara S, Fukuroda T, Nishikibe M. Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis. Biochem Biophys Res Commun 2009;384:173–179.
   PubMed Web of Science ®Google Scholar
• Chen M, Curtis TM, Stitt AW. Advanced glycation end products and diabetic retinopathy. Curr Med Chem 2013;20:3234–3240.
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Matsui T, Ueda S, Fukami K, Yamagishi S. Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression. Cardiovasc Diabetol 2014. 2014;13:60.
   PubMed Web of Science ®Google Scholar
• Liu J, Schuff-Werner P, Steiner M. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 2006;343:183–189.
   PubMed Web of Science ®Google Scholar
• Han N, Jin K, He K, Cao J, Teng L. Protease-activated receptors in cancer: a systematic review. Oncol Lett 2011;2:599–608.
   PubMed Web of Science ®Google Scholar
• Zania P, Papaconstantinou M, Flordellis CS, Maragoudakis ME, Tsopanoglou NE. Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms. Am J Physiol Cell Physiol 2008;294:C1215–C1226.
   Google Scholar
• Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006;10:355–362.
   PubMed Web of Science ®Google Scholar
• Dai Y, Wu Z, Sheng H, Zhang Z, Yu M, Zhang Q. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Mol Vis 2015;21:417–427.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Sonoda KH, Sugahara M, Mochizaki Y, Enaida H, Oshima Y, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009;4(12):e8158.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, et al. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Am J Ophthalmol 1997;123:599–606.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006;12:867–878.
   PubMed Web of Science ®Google Scholar
• Xue M, Hollenberg MD, Yong VW. Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci 2006;26:10281–10291.
   PubMed Web of Science ®Google Scholar
• Xue M, Hollenberg MD, Demchuk A, Yong VW. Relative importance of proteinase-activated receptor-1 versus matrix metalloproteinases in intracerebral hemorrhage-mediated nerurotoxicity in mice. Stroke 2009;40:2199–2204.
   PubMed Web of Science ®Google Scholar
• Xue M, Fan Y, Liu S, Zygun DA, Demchuk A, Yong VW. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain 2009;132:26–36.
   PubMed Web of Science ®Google Scholar
• Chen B, Cheng Q, Yang K, Lyden PD. Thrombin mediates severe neurovascular injury during ischemia. Stroke 2010;41:2348–2352.
   PubMed Web of Science ®Google Scholar
• Pulukuri SM, Rao JS. Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol 2008;32:757–765.
   PubMed Web of Science ®Google Scholar
• Goerge T, Barg A, Schnaeker EM, Poppelmann B, Shpacovitch V, Rattenholl A, et al. Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res 2006;66:7766–7774.
   PubMed Web of Science ®Google Scholar
• Blackburn JS, Rhodes CH, Coon CI, Brinckerhoff CE. RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res 2007;67:10849–10858.
   PubMed Web of Science ®Google Scholar
• Eck SM, Hoopes PJ, Petrella BL, Coon CI, Brinckerhoff CE. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat 2009;116:79–90.
   PubMed Web of Science ®Google Scholar
• Juncker-Jensen A, Deryugina E, Rimann I, Zajac E, Kupriyanova TA, Engelholm LH, et al. Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination. Cancer Res 2013;73:4196–4211.
   PubMed Web of Science ®Google Scholar
• Ferris FL 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 1984;28(Suppl):452–461.
   Google Scholar